Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Applied DNA Sciences Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Applied DNA Sciences Inc : Applied DNA Sciences Continues Expansion in Sweden

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/11/2012 | 04:40am CEST
Applied DNA Sciences Continues Expansion in Sweden Security Giant Nokas Adopts DNA Evidentiary Marking

MEDIA CONTACT: Mitchell Miller, 646-543-3373, fax: 631-444-8848

INVESTOR CONTACT: Debbie Bailey, 631-444-8090, fax: 631-444-8848

FCMN Contact: info@adnas.com

PROGRAM CONTACT: Leif Svensson, CEO, Safe Solution AB, +46 76-774 44 14

Web site: http://www.adnas.com

Twitter: @APDN, @APDNInvestor

STONY BROOK, NY, December 10, 2012. Applied DNA Sciences, Inc. (OTC Bulletin Board: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its evidentiary DNA platform has been adopted in Sweden for use in helping protect cash in transit in that country. The security company Nokas AS revealed that APDN's marking and authentication

platform will first be deployed in armored vehicles in the Stockholm area and then expanded to the company's
entire fleet.
The technology comes into play during a robbery, when botanically-based DNA marks within a water-based spray are released on cash notes and the criminals themselves. The marks can survive on the notes, clothes, and skin for long periods of time. In court, they provide accepted evidence directly linking criminals to the crime.
Nokas, based in Norway, fields a fleet of over 250 armored trucks to transport cash. It is one of only two cash transport companies in Sweden servicing many retail chains, large banks and other institutions.
The APDN platform for cash in transit already has been used with great success in the United Kingdom, where DNA evidence has helped in over fifty convictions of armed and dangerous criminals since 2009, in an environment where front-line police and private guards are typically unarmed. The DNA marking and authentication platform protects more than 26% of cash being transported to and from banks in the United Kingdom.
Johan Petersson, Nokas security officer, commented, "This is an exciting development for the entire security industry. We are the first with new technology in cash in transit in this region, which helps deter crime and helps the judiciary to prosecute any offense. Using this new technology, Nokas will provide added security to its staff and customers. We believe we are at the forefront."
Elsewhere in Sweden, adoption of the APDN DNA platform has been expanding.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on APPLIED DNA SCIENCES INC
09/14 APPLIED DNA SCIENCES : Introduces SigNature(R) DNA Molecular Taggants to Pharmac..
09/07 APPLIED DNA SCIENCES : Expands US Cotton Tagging Business With Launch of New "Ho..
09/06 APPLIED DNA SCIENCES : Platform Stops Cotton Fiber Substitution
08/23 Applied DNA Sciences to Present at the 5th Annual Liolios Gateway Conference ..
08/11 APPLIED DNA SCIENCES : reports 3Q loss
08/11 APPLIED DNA SCIENCES : Management's Discussion and Analysis of Financial Conditi..
08/11 APPLIED DNA SCIENCES INC : Results of Operations and Financial Condition, Financ..
08/11 APPLIED DNA SCIENCES : Reports Fiscal Third Quarter 2016 Results
08/09 APPLIED DNA SCIENCES : and BLC Leather Technology Centre Ltd to Improve Transpar..
08/02 APPLIED DNA SCIENCES INC : Change in Directors or Principal Officers, Financial ..
More news
Sector news : Specialty Chemicals
09/29 New Adidas CEO sets off in pursuit of Nike
09/29DJNew Adidas CEO Confronts 'High Bar'
09/19DJUnilever Buys 'Green' Products Maker Seventh Generation
09/13DJBusiness Watch -- WSJ -2-
09/13DJBusiness Watch -- WSJ
More sector news : Specialty Chemicals
Advertisement
Financials ($)
Sales 2016 7,53 M
EBIT 2016 -6,17 M
Net income 2016 -6,10 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 9,82x
Capi. / Sales 2017 4,03x
Capitalization 73,9 M
More Financials
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 8,00 $
Spread / Average Target 161%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
James A. Hayward Chairman, President & Chief Executive Officer
Beth Jantzen Chief Financial Officer
Ming-Hwa Benjamin Liang Secretary & Chief Scientific Officer
Judith Murrah Chief Information Officer
Sanford R. Simon Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
APPLIED DNA SCIENCES I..74
SASOL LIMITED-10.15%17 846
SIKA AG31.27%10 332
SYMRISE AG5.97%9 463
JOHNSON MATTHEY PLC21.45%8 231
CRODA INTERNATIONAL PL..13.84%5 892
More Results